Abstract
The search of highly efficient drugs for overcoming cancer drug resistance continues to be a challenge for scientists. Constructing a metal drug based in situ oxidation-state transition system to disturb the redox balance in cancer cells is a promising approach for overcoming cancer drug resistance. Inspired by natural redox-active copper enzyme centers, we developed a Cu(I)-Cu(II) in situ transition system in this work. Through atom engineering, we fine-tuned the thermodynamic stability of this system to investigate its anticancer activity The results indicated that the synthetic Cu(I)-Cu(II) system could under-go in situ transition in vitro and in vivo, to disrupt the intracellular redox balance and trigger mitochondrial dysfunction and G2/M arrest, leading to apoptosis and overcoming cancer drug resistance This study presents a feasible way to overcome cancer drug resistance by designing an in situ oxidation-state transition metal drug system.
References
Vasan N, Baselga J, Hyman DM. Nature, 2019, 575: 299–309
Robey RW, Pluchino KM, Hall MD, Fojo AT, Bates SE, Gottesman MM. Nat Rev Cancer, 2018, 18: 452–464
Housman G, Byler S, Heerboth S, Lapinska K, Longacre M, Snyder N, Sarkar S. Cancers, 2014, 6: 1769–1792
Ruan L, Chen J, Du C, Lu H, Zhang J, Cai X, Dou R, Lin W, Chai Z, Nie G, Hu Y. Bioactive Mater, 2022, 13: 191–199
Huang W, Chen Z, Hou L, Feng P, Li Y, Chen T. Dalton Trans, 2020, 49: 11556–11564
Peng K, Liang BB, Liu W, Mao ZW. Coord Chem Rev, 2021, 449: 214210
Wang H, Wu H, Yi Y, Xue K, Xu J, Wang H, Zhao Y, Zhang X. CCS Chem, 2021, 3: 1413–1425
Loehrer PJ, Einhorn LH. Ann Intern Med, 1984, 100: 704–713
Wang D, Lippard SJ. Nat Rev Drug Discov, 2005, 4: 307–320
Jin S, Guo Y, Guo Z, Wang X. Pharmaceuticals, 2021, 14: 133
Li SH, Wu CY, Tang X, Gao SP, Zhao XQ, Yan H, Wang XM. Sci China Chem, 2013, 56: 595–603
Wang Z, He L, Liu B, Zhou LP, Cai LX, Hu SJ, Li XZ, Li Z, Chen T, Li X, Sun QF. J Am Chem Soc, 2020, 142: 16409–16419
Bell CC, Fennell KA, Chan YC, Rambow F, Yeung MM, Vassiliadis D, Lara L, Yeh P, Martelotto LG, Rogiers A, Kremer BE, Barbash O, Mohammad HP, Johanson TM, Burr ML, Dhar A, Karpinich N, Tian L, Tyler DS, MacPherson L, Shi J, Pinnawala N, Yew Fong C, Papenfuss AT, Grimmond SM, Dawson SJ, Allan RS, Kruger RG, Vakoc CR, Goode DL, Naik SH, Gilan O, Lam EYN, Marine JC, Prinjha RK, Dawson MA. Nat Commun, 2019, 10: 1–5
Li J, Zeng L, Wang Z, Chen H, Fang S, Wang J, Cai C, Xing E, Liao X, Li Z, AshbyJr CR, Chen Z, Chao H, Pan Y. Adv Mater, 2022, 34: 2100245
Zhang C, Liu X, Jin S, Chen Y, Guo R. Mol Cancer, 2022, 21: 47
Wang L, Zhang W, Wang S, Gao Z, Luo Z, Wang X, Zeng R, Li A, Li H, Wang M, Zheng X, Zhu J, Zhang W, Ma C, Si R, Zeng J. Nat Commun, 2016, 7: 14036
Zhang Y, Sha R, Zhang L, Zhang W, Jin P, Xu W, Ding J, Lin J, Qian J, Yao G, Zhang R, Luo F, Zeng J, Cao J, Wen LP. Nat Commun, 2018, 9: 4236
Zhang H, Zhang Y, Cao J, Ma L, Chen T. Chem Commun, 2022, 58: 3759–3762
Liu Z, Li T, Li N, Wang Y, Chen L, Tang X, Wan M, Mao C. Sci China Chem, 2022, 65: 989–1002
Ji X, Ge L, Liu C, Tang Z, Xiao Y, Chen W, Lei Z, Gao W, Blake S, De D, Shi B, Zeng X, Kong N, Zhang X, Tao W. Nat Commun, 2021, 12: 1124
Xie L, Wang L, Guan R, Ji L, Chao H. J Inorg Biochem, 2021, 217: 111380
Chen M, Huang X, Shi H, Lai J, Ma L, Lau TC, Chen T. Biomaterials, 2021, 276: 120991
Xia X, Wang R, Hu Y, Yao Q, Long S, Sun W, Fan J, Peng X. Sci China Chem, 2022, 65: 821–828
Tsvetkov P, Coy S, Petrova B, Dreishpoon M, Verma A, Abdusamad M, Rossen J, Joesch-Cohen L, Humeidi R, Spangler RD, Eaton JK, Frenkel E, Kocak M, Corsello SM, Lutsenko S, Kanarek N, Santagata S, Golub TR. Science, 2022, 375: 1254–1261
Bím D, Alexandrova AN. Chem Sci, 2021, 12: 11406–11413
King JD, Mcintosh CL, Halsey CM, Lada BM, Niedzwiedzki DM, Cooley JW, Blankenship RE. Biochemistry, 2013, 52: 8267–8275
Xiang S, Liu Y. Univ Chem, 2022, 37: 2107128
Vallee BL, Williams RJP. Proc Natl Acad Sci USA, 1968, 59: 498–505
Rhoda HM, Heyer AJ, Snyder BER, Plessers D, Bols ML, Schoonheydt RA, Sels BF, Solomon EI. Chem Rev, 2022, 122: 12207–12243
Hagen WR. Metallomics, 2019, 11: 1768–1778
Chaka G, Sonnenberg JL, Schlegel HB, Heeg MJ, Jaeger G, Nelson TJ, Ochrymowycz LA, Rorabacher DB. J Am Chem Soc, 2007, 129: 5217–5227
Cao Y, Saygili Y, Ummadisingu A, Teuscher J, Luo J, Pellet N, Giordano F, Zakeeruddin SM, Moser JE, Freitag M, Hagfeldt A, Grätzel M. Nat Commun, 2017, 8: 15390
Dicke B, Hoffmann A, Stanek J, Rampp MS, Grimm-Lebsanft B, Biebl F, Rukser D, Maerz B, Göries D, Naumova M, Biednov M, Neuber G, Wetzel A, Hofmann SM, Roedig P, Meents A, Bielecki J, Andreasson J, Beyerlein KR, Chapman HN, Bressler C, Zinth W, Rübhausen M, Herres-Pawlis S. Nat Chem, 2018, 10: 355–362
Frisch M, Trucks G, Schlegel H, Scuseria G, Robb M, Cheeseman J, Scalmani G, Barone V, Mennucci B, Petersson G, et al. Gaussian 09. Wallingford, CT: Gaussian Inc., 2009. 150–166
Duxbury DF. Chem Rev, 1993, 93: 381–433
Becke AD. Phys Rev A, 1988, 38: 3098–3100
Weigend F, Ahlrichs R. Phys Chem Chem Phys, 2005, 7: 3297–3305
Zhao R, Wu Y, Zhang Y, Ling J, Liu X, Xiang J, Zeng X, Chen T. Sci China Chem, 2022, 65: 694–698
Acknowledgements
This work was supported by National Natural Science Foundation of China (21877049, 22177038, 32171296), Guangdong Natural Science Foundation (2020B1515120043, 2022A1515012235), the Major Program for Tackling Key Problems of Industrial Technology in Guangzhou (201902020013), Guangdong Pearl River Talent Program (2017GC010354), and the Innovation Team Project in Guangdong Colleges and Universities (2019KCXTD008, 2019KTSCX012).
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest The authors declare no conflict of interest.
Additional information
Supporting information The supporting information is available online at http://chem.scichina.com and http://link.springer.com/journal/11426. The supporting materials are published as submitted, without typesetting or editing. The responsibility for scientific accuracy and content remains entirely with the authors.
Supporting Information
11426_2022_1340_MOESM1_ESM.pdf
Atom Engineering-Regulated In Situ Transition of Cu(I)-Cu(II) Entatic State for Efficient Overcoming Cancer Drug Resistance
Rights and permissions
About this article
Cite this article
Zhang, Y., Chen, M., Wang, J. et al. Atom engineering-regulated in situ transition of Cu(I)-Cu(II) for efficiently overcoming cancer drug resistance. Sci. China Chem. 65, 1879–1884 (2022). https://doi.org/10.1007/s11426-022-1340-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11426-022-1340-6